ZBiotics is a synthetic biology company founded in 2016 and headquartered in San Francisco, California. The company bioengineers probiotic bacteria for nutraceutical and other applications. They launched the world's first genetically engineered probiotic in 2019 – a probiotic that breaks down a toxic byproduct of alcohol. They are currently developing a pipeline of additional engineered probiotics for other consumer health applications.
I have a PhD in microbiology & immunology from the University of Michigan, where I enjoyed my research untangling complex and elegant webs of bacterial gene regulation. I did my undergrad at UC Berkeley, where I double-majored in immunology and classical art & archaeology. Prior to starting ZBiotics in 2016 and inventing our proprietary technology, I worked in clinical trial design as well as researching HIV vaccines and pursuing novel antibiotics in both academia and industry.
Co-founder/COO at ZBiotics. Former experience in corporate real estate management, new market entry, and cross-border transactions. JD/MBA from Penn Law/Wharton.